HALO — Halozyme Therapeutics Inc

AI Signal & Stock Analysis · Very Strong ↑

As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for HALO is Very Strong ↑; the stock is at $98.41 (-2.24% today); overbought (RSI 73); technical trend is Raise; news sentiment is positive.

Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• RSI is overbought
• Relative volume 0.61× (light)
• Technical trend is Raise
• News sentiment is positive
• 6% below its 52-week high
• 61% above its 52-week low

Frequently asked about HALO

What is AkshayaAI's signal for HALO today?

As of Aug 14 2026, 1:04 PM, AkshayaAI assigns HALO (Halozyme Therapeutics Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.

Is HALO overbought or oversold right now?

HALO's RSI is overbought (RSI 73). A reading above 70 is typically considered overbought and below 30 oversold.

Where is HALO in its 52-week range?

HALO is trading about 6% below its 52-week high and 61% above its 52-week low as of Aug 14 2026, 1:04 PM.

When is HALO's next earnings date?

HALO's next earnings date is 8/6/2026 4:30:00 PM.

What sector is HALO in?

HALO is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.